Blue Belt Technologies (“Blue Belt”) is one of three orthopedic surgical robotics companies. Its core product allows the general orthopedist to perform joint replacement procedures with consistency and confidence. The company has proprietary robotic technology and tools for use in minimally invasive computer-assisted orthopedic, neurosurgical, craniomaxillofacial (CMF) and ear, nose and throat (ENT) procedures. Blue Belt represents a key beachhead in the development of Fund III’s continuum of care strategy and is particularly focused on the knee and hip markets.


ProSomnus Sleep Technologies, Inc. is a privately held company and wholly-owned subsidiary of ProSomnus Holdings located in Dublin, California that invents and manufactures custom intraoral devices that enable dentists to treat Obstructive Sleep Apnea (OSA) with greater effectiveness, efficiency and convenience. The Company has developed a disruptive, next generation Oral Appliance Platform for the treatment of Obstructive Sleep Apnea and Snoring. The Company’s first and flagship product is called the MicrO2 Sleep & Snore Device, which utilizes a unique titration (adjustment) system and is designed to be smaller, stronger and more precise than competitive oral appliances. The Company produces the MicrO2 device through its unique precision manufacturing platform that enables dentists to implement their treatment plan with more predictability and optimization, and affords a more comfortable treatment and a shorter mean timeframe to treatment for the patient.


China Rehabilitation, Ltd. (formerly ChinaRehab now renamed “SinoRehab”) is a company formed in Beijing, China that will provide post-operative, outpatient orthopedic rehabilitation services to private pay patients who have recently undergone orthopedic surgical interventions. The pilot rehabilitation facility has now been located adjacent to Beijing’s leading orthopedic hospital, Ji Shui Tan (“JST”). The business plan is to roll out a chain of branded for-profit outpatient facilities starting in Beijing and expanding to other major cities.


Alphatec Spine, Inc. (NASDAQ: ATEC) is a medical technology company focused on the design, development and marketing of products for the treatment of spine disorders. The Company develops products and systems that seek to address the entire spinal fusion procedure in the most effective and efficient way possible. The product design focus is on simplifying procedures for the surgeon with the ultimate objective of improving patient outcomes.


BioHorizons, Inc. is a medical technology company focused on developing, manufacturing and marketing a broad line of innovative, proprietary and evidence-based dental implants, as well as hard and soft tissue regeneration products, for the replacement of missing teeth. The company has designed its dental implant product portfolio to address the clinical requirements in implant dentistry. The company is the sixth-largest dental implant company in the North American market and has been growing faster than the market due to its patented technology, successful new product launches and customer service. BioHorizons has 321 employees worldwide.


OrthoSpace Ltd. is a privately held company located in Caesarea, Israel, that offers disruptive technology for the treatment of severe rotator cuff (“RC”) tears, a large market segment with limited treatment options and little historic innovation. InSpace, OrthoSpace’s flagship product, is an orthopedic biodegradable balloon system. The InSpace procedure is a simple, safe and minimally invasive method that addresses an unmet clinical need.


OrthoAccel is a medical device company located in Houston, Texas that has now established its position as “first mover” in the emerging discipline of accelerated orthodontics. The company’s principal product is the AcceleDentTM.


Nexa Orthopedics, Inc. was founded in 2004 by HealthpointCapital to create the pre-eminent company in extremities surgery through a program of business investments, technology in-licensing, internal development, and acquisition. The investment opportunity in the highly fragmented market was based on consolidation and scale and driven by differentiated technology.

In February 2005, Nexa acquired Futura Biomedical, LLC. Futura manufactured and distributed the only complete line of forefoot arthroplasty products and was a leading innovator of implants for the correction of flexible flatfood deformities. In the summer of 2005, Nexa acquired the StayFuse product line from Pioneer Surgical. Nexa also partners with OsteoBiologics, Inc. for U.S. distribution of OBI products in hand, foot and ankle surgery. In November 2005, Nexa acquired BioProfile S.S, a French manufacturer of orthopedic extremity products utilizing its novel pryocarbon. In September 2006, Nexa acquired Axiom Orthopaedics, Inc., a leading innovator in the shoulder arthroplasty market.

HealthpointCapital sold Nexa Orthopedics, Inc. to Tornier in February 2007. The sale of Nexa provided HeathpointCapital Partners, L.P. a 75% internal rate of return on its investment.